Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017398 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-08 | 2022-03-07 | ADPT | BENZENO SHARON | Chief Business Development Off | S - Sale | $12.01 | -2,670 | 102.6K | -3% | -$32.1K |
| D | 2022-03-08 | 2022-03-04 | ADPT | BENZENO SHARON | Chief Business Development Off | A - Grant | $0.00 | +82.4K | 105.3K | +360% | $0 |
| D | 2022-03-08 | 2022-03-04 | ADPT | BENZENO SHARON | Chief Business Development Off | A - Grant | $0.00 | +205.9K | 205.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | S | D | 2,670 | $12.01 | 102,596 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-04 | A | A | 82,372 | $0.00 | 105,266 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-04 | A | A | 205,931 | $0.00 | 205,931 | D | $12.14 · — to 2032-03-04 | 205,931 Common Stock | (F2) The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |